Novel Resveratrol and 5-Fluorouracil Coencapsulated in PEGylated Nanoliposomes Improve Chemotherapeutic Efficacy of Combination against Head and Neck Squamous Cell Carcinoma
Figure 9
Expression levels of bax, bacl-2, caspase-3, and cyclin D1 in cells treated with resveratrol (31 μM), 5-FU (2.6 μM), and PEGylated dual drug loaded liposomes (containing 2.5 μM of 5-FU and 5 μM of resveratrol); R—resveratrol, F—5-FU and DL—dual drug loaded PEGylated liposomes, and cells—untreated cells. ∗signifies that the groups are significantly different from the DL group ().
